Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VALID II paediatric valacyclovir oral solution pharmacokinetics study
NL-OMON50198Phase 4Active, not recruiting
- Sponsor
- Ziekenhuisapotheek
- Start
- Jan 2020
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of valaciclovir in Varicella zoster infection and herpes simplex (HSV), sponsored by Ziekenhuisapotheek. Primary endpoints: AUC0-12 of acyclovir, Cmax of acyclovir and 1 more. Started Jan 2020; status: active, not recruiting.
02
Drugs
valaciclovir
03
Conditions
Varicella zoster infectionherpes simplex (HSV)
Beyond the preview
Go deeper on NL-OMON50198.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON50198.